Home   Chapter Home   Jobs   Conferences   Fellowships   Books


Chronic Myeloid Neoplasms


Myeloid neoplasm associated with FGFR1 rearrangement

Reviewer: Nikhil Sangle, M.D. (see Reviewers page)
Revised: 10 August 2011, last major update August 2011
Copyright: (c) 2001-2011, PathologyOutlines.com, Inc.


● First described in 1995 as 8p11 myeloproliferative syndrome (Leukemia 1995;9:1628); previously called stem cell leukemia-lymphoma syndrome
● Aggressive hematologic malignancy characterized by myeloid hyperplasia, eosinophilia and precursor lymphoblastic lymphoma, usually T cell type (Acta Haematol 2002;107:101, Am J Surg Pathol 2008;32:14)
● Can present as myeloproliferative neoplasm or in transformation as AML

Case reports

● 19 year old woman with axillary nodule (Univ Pittsburgh Case of Month)


● Bone marrow examination with tryptase stain, T cell clonal studies
● Use of immunostains, cytogenetics and molecular studies to detect FGFR1 rearrangement and absence of BCR-ABL

Micro description

Peripheral blood: eosinophila and neutrophilia, with occasionally monocytosis
Bone marrow: hypercellular with myeloid hyperplasia and eosinophilia, no increased blasts, no dysplastic features

Micro images

Various images

Molecular description

● Balanced translocations with 8p11, most commonly t(8;13)(p11;q12) - FGFR1 and ZNF198 (Blood 1998;92:1735)
● 8p11 may also involve MOZ gene, a putative histone acetyltransferase, associated with AML-M4/M5 (Blood 1997;90:3130)
● t(5;12)(q33;p13) creating PDGFRB and ETV6 is associated with chronic myelomonocytic leukemia with eosinophilia (Acta Haematol 2002;107:113)
● FGFR1 associated with leukemia/lymphoma should be classified as leukemia/lymphoma associated with FGFR1 rearrangement

Molecular images/tables

Table of FGFR1 gene partners

FISH assay of FIM (also called ZNF198) and FGFR1

Differential diagnosis

● Chronic eosinophilic leukemia - not otherwise categorized or hypereosinophilic syndrome (no FGFR1 rearrangement)

End of Chronic Myeloid Neoplasms > MDS/MPN > Myeloid neoplasm associated with FGFR1 rearrangement

This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.

All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at [email protected] with any questions (click here for other contact information).